CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease
Examination of CSF proteins in mutation carriers and non-carriers for autosomal dominant Alzheimer’s disease uncovers early proteomic changes and generates a robust ADAD prediction model.
The findings highlight the similarities and differences between ADAD and sporadic Alzheimer’s disease, which can lead to personalized medicine for mutation carriers in ADAD genes.
